A Sativex®-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Sativex®-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 172, Issue 14, Pages 3579-3595
Publisher
Wiley
Online
2015-04-08
DOI
10.1111/bph.13159
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Changes in Endocannabinoid Receptors and Enzymes in the Spinal Cord of SOD1G93ATransgenic Mice and Evaluation of a Sativex®-like Combination of Phytocannabinoids: Interest for Future Therapies in Amyotrophic Lateral Sclerosis
- (2014) Miguel Moreno-Martet et al. CNS Neuroscience & Therapeutics
- Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review
- (2014) Latha Velayudhan et al. CURRENT PHARMACEUTICAL DESIGN
- The Concise Guide to PHARMACOLOGY 2013/14: Nuclear Hormone Receptors
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Concise Guide to PHARMACOLOGY 2013/14: Enzymes
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Chondroitin sulfate proteoglycans inhibit oligodendrocyte myelination through PTPσ
- (2013) James C. Pendleton et al. EXPERIMENTAL NEUROLOGY
- Inhibitors of myelination: ECM changes, CSPGs and PTPs
- (2013) Danielle E. Harlow et al. EXPERIMENTAL NEUROLOGY
- Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain
- (2013) Antonio García-Merino Expert Review of Neurotherapeutics
- Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial
- (2013) John Zajicek et al. LANCET NEUROLOGY
- Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
- (2013) M. Mecha et al. NEUROBIOLOGY OF DISEASE
- The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
- (2013) Adam J. Pawson et al. NUCLEIC ACIDS RESEARCH
- Genetic Background Can Result in a Marked or Minimal Effect of Gene Knockout (GPR55 and CB2 Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis
- (2013) Sofia Sisay et al. PLoS One
- Sativex-like Combination of Phytocannabinoids is Neuroprotective in Malonate-Lesioned Rats, an Inflammatory Model of Huntington’s Disease: Role of CB1 and CB2 Receptors
- (2012) Sara Valdeolivas et al. ACS Chemical Neuroscience
- Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination
- (2012) Lorraine W. Lau et al. ANNALS OF NEUROLOGY
- Cortical remyelination: A new target for repair therapies in multiple sclerosis
- (2012) Ansi Chang et al. ANNALS OF NEUROLOGY
- Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
- (2012) Javier Fernández-Ruiz et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Potential Control of Multiple Sclerosis by Cannabis and the Endocannabinoid System
- (2012) Gareth Pryce et al. CNS & Neurological Disorders-Drug Targets
- Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis
- (2012) Michael G. Serpell et al. JOURNAL OF NEUROLOGY
- Viral models of multiple sclerosis: Neurodegeneration and demyelination in mice infected with Theiler's virus
- (2012) Miriam Mecha et al. PROGRESS IN NEUROBIOLOGY
- Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress
- (2012) M Mecha et al. Cell Death & Disease
- Chondroitin sulphate proteoglycans: Extracellular matrix proteins that regulate immunity of the central nervous system
- (2011) Sarah Haylock-Jacobs et al. AUTOIMMUNITY REVIEWS
- Distinct Spatio-Temporal Extracellular Matrix Accumulation within Demyelinated Spinal Cord Lesions in Theiler's Murine Encephalomyelitis
- (2011) Verena Haist et al. BRAIN PATHOLOGY
- Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice
- (2011) Ewa Kozela et al. BRITISH JOURNAL OF PHARMACOLOGY
- THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis
- (2011) Jaume Sastre-Garriga et al. Expert Review of Neurotherapeutics
- Astrocyte phenotypes and their relationship to myelination
- (2011) Besma Nash et al. JOURNAL OF ANATOMY
- The inhibitory effects of chondroitin sulfate proteoglycans on oligodendrocytes
- (2011) Justin R. Siebert et al. JOURNAL OF NEUROCHEMISTRY
- Smad proteins differentially regulate transforming growth factor-β-mediated induction of chondroitin sulfate proteoglycans
- (2011) Bala T. S. Susarla et al. JOURNAL OF NEUROCHEMISTRY
- Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement
- (2011) Giuseppe Esposito et al. PLoS One
- Guidelines for reporting experiments involving animals: the ARRIVE guidelines
- (2010) JC McGrath et al. BRITISH JOURNAL OF PHARMACOLOGY
- Animal research: Reporting in vivo experiments: The ARRIVE guidelines
- (2010) Carol Kilkenny et al. BRITISH JOURNAL OF PHARMACOLOGY
- The endocannabinoid system as a target for the treatment of neuronal damage
- (2010) Javier Fernández-Ruiz et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The constitutive production of the endocannabinoid 2-arachidonoylglycerol participates in oligodendrocyte differentiation
- (2010) Oscar Gomez et al. GLIA
- Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis
- (2010) Derick T Wade et al. Multiple Sclerosis Journal
- Cannabinoid activation of peroxisome proliferator-activated receptors: Potential for modulation of inflammatory disease
- (2009) S.E. O'Sullivan et al. IMMUNOBIOLOGY
- The nuclear receptor PPARγ selectively inhibits Th17 differentiation in a T cell–intrinsic fashion and suppresses CNS autoimmunity
- (2009) Luisa Klotz et al. JOURNAL OF EXPERIMENTAL MEDICINE
- An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis
- (2009) F. Loría et al. NEUROBIOLOGY OF DISEASE
- Remyelination capacity of the MS brain decreases with disease chronicity
- (2009) T. Goldschmidt et al. NEUROLOGY
- Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
- (2009) Angelo A. Izzo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Deoxyribozyme-mediated knockdown of xylosyltransferase-1 mRNA promotes axon growth in the adult rat spinal cord
- (2008) Andres Hurtado et al. BRAIN
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
- A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules
- (2008) L. Mestre et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Limited remyelination in Theiler's murine encephalomyelitis due to insufficient oligodendroglial differentiation of nerve/glial antigen 2 (NG2)-positive putative oligodendroglial progenitor cells
- (2008) R. Ulrich et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- CB2cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies
- (2007) Arévalo-Martín et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now